Source Natural Foods & Herbal Supplements Surges to All-Time High, Outperforms Sector and Sensex

Oct 06 2024 09:20 AM IST
share
Share Via
Source Natural Foods & Herbal Supplements, a microcap company in the pharmaceuticals and drugs industry, has recently reached an all-time high stock price of Rs. 238 on October 6th, 2024. Despite a slight decrease in performance after 9 consecutive days of gains, the stock is still trading higher than its moving averages and has outperformed the Sensex in the past year.

Source Natural Foods & Herbal Supplements, a microcap company in the pharmaceuticals and drugs industry, has recently seen a surge in its stock price. On October 6th, 2024, the company's stock reached an all-time high of Rs. 238, breaking its previous 52-week high.

According to MarketsMOJO, a leading stock analysis and recommendation platform, the current stock call for Source Natural Foods & Herbal Supplements is 'Hold'. This suggests that investors should hold onto their existing shares and not make any new purchases or sales.

In terms of performance, Source Natural Foods & Herbal Supplements has underperformed the sector by -6.22% on the day of its all-time high. This could be due to the fact that the stock has fallen after 9 consecutive days of gains. Additionally, the stock opened with a loss of -5.11% today and touched an intraday low of Rs. 222.3, which is a decrease of -6.56%.

However, despite these recent fluctuations, Source Natural Foods & Herbal Supplements is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.

In terms of overall performance, Source Natural Foods & Herbal Supplements has outperformed the Sensex, with a 1-year performance of 152.16% compared to the Sensex's 25.24%. This showcases the company's strong growth and potential in the market.

As a microcap company, Source Natural Foods & Herbal Supplements may not be on the radar of many investors. However, its recent surge in stock price and positive performance suggest that it may be worth keeping an eye on in the pharmaceuticals and drugs industry.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News